Antonia Netzl

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Mapping SARS-CoV-2 immunity after an XBB.1.5 booster by antigenic cartography of merged human and hamster sera.

Mapping SARS-CoV-2 immunity after an XBB.1.5 booster by antigenic cartography of merged human and hamster sera.

Journal: NPJ vaccines
Published: December 12, 2025

Exposure to two antigenically distinct SARS-CoV-2 variants broadens neutralization patterns.

Exposure to two antigenically distinct SARS-CoV-2 variants broadens neutralization patterns.

Journal: Vaccine
Published: April 25, 2025

Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variants.

Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variants.

Journal: Scientific reports
Published: April 04, 2025

Nonhuman primate antigenic cartography of SARS-CoV-2.

Nonhuman primate antigenic cartography of SARS-CoV-2.

Journal: Cell reports
Published: August 24, 2024

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Journal: Nature communications
Published: July 19, 2024

Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.

Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.

Journal: Science translational medicine
Published: May 15, 2024

Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.

Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.

Journal: NPJ vaccines
Published: January 22, 2024

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.

Journal: bioRxiv : the preprint server for biology
Published: October 09, 2023

Mapping SARS-CoV-2 antigenic relationships and serological responses.

Mapping SARS-CoV-2 antigenic relationships and serological responses.

Journal: Science (New York, N.Y.)
Published: October 05, 2023

Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster.

Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster.

Journal: The Journal of infectious diseases
Published: September 11, 2023

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.

Journal: The Journal of infectious diseases
Published: July 22, 2023

Protocol to isolate nuclei from Chlamydomonas reinhardtii for ATAC sequencing.

Protocol to isolate nuclei from Chlamydomonas reinhardtii for ATAC sequencing.

Journal: STAR protocols
Published: July 13, 2023
Showing 1-12 of 22

Last Updated: 09/26/2026